American Heart Association: Novel gene-editing therapy shows promise for patients with transthyretin amyloid cardiomyopathy

Hello HCIS,

Thank you for your interest in news from the American Heart Association. Click below to see the latest updates:

November 05, 2022
Novel gene-editing therapy shows promise for patients with transthyretin amyloid cardiomyopathy

https://newsroom.heart.org/news/novel-gene-editing-therapy-shows-promise-for-patients-with-transthyretin-amyloid-cardiomyopathy

---

Click below to unsubscribe from American Heart Association email alerts.

Unsubscribe